col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt

Verlag: Portland Press

110 Ergebisse       Seite 1

 [1] 
  Original Artikel Journal Datum Titel Autoren Max. 6 Autoren
1 [GO] Clinical Science 2024―Dez―12 Harnessing 2D and 3D human endometrial cell culture models to investigate SARS-CoV-2 infection in early pregnancy. Madhuri Salker, Anna Liu, Natalia Ruetalo, Janet Pushpa Raja Xavier, Aditya Kumar Lankapalli, Jakob Admard, Miguel Camarena-Sainz, Sara Brucker, Yogesh Singh, Michael Schindler
2 [GO] Bioscience Reports 2024―Dez―10 Does COVID-19 impact the QT interval prolongation? Answers from genetic causal inference Yongfei Song, Zequn Zheng
3 [GO] Biochemical Society Transactions 2024―Sep―02 Human E3 ubiquitin ligases: accelerators and brakes for SARS-CoV-2 infection Jesse Pellman, Anna Goldstein, Mikołaj Słabicki
4 [GO] Bioscience Reports 2024―Jul―24 Boosting Immunity: Synergistic Antiviral Effects of Luteolin, Vitamin C, Magnesium, and Zinc Against SARS-CoV-2 3CLpro Juliana C. Ferreira, Samar Fadl, Thyago H. S. Cardoso, Bruno Andrade, Tarcisio S. Melo, Edson M.A. Silva, Anupriya Agarwal, Stuart Turville, Nitin K. Saksena, Wael M. Rabeh
5 [GO] Bioscience Reports 2024―Jul―22 3C-like proteases in SARS-CoV-2 Kenana Al Adem, Juliana C. Ferreira, Adrian J. Villanueva, Samar Fadl, Farah El-Sadaany, Imen Masmoudi, Yugmee Gidiya, Tariro Gurudza, Thyago H. S. Cardoso, Nitin K. Saksena, Wael M. Rabeh
6 [GO] Biochemical Journal 2024―Mai―07 Efficient overexpression and purification of SARS-CoV-2 Nucleocapsid proteins in Escherichia coli Emma L Brudenell, Manoj B Pohare, Domen Zafred, Janine Phipps, Hailey R Hornsby, John Darby, Junxiao Dai, Ellen Liggett, Kathleen Cain, Perdita Barran, Thushan I de Silva, Jon R Sayers
7 [GO] Clinical Science 2024―Apr―04 Correction: The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease
8 [GO] Clinical Science 2024―Feb―19 COVID-19 and abnormal uterine bleeding: potential associations and mechanisms Jacqueline A. Maybin, Marianne Watters, Bethan Rowley, Catherine A. Walker, Gemma C. Sharp, Alexandra Alvergne
9 [GO] Bioscience Reports 2023―Dez―22 SARS-CoV-2 NSP14 MTase activity is critical for inducing canonical NF-κB activation Marie J Tofaute, Benjamin Weller, Carina Graß, Hridi Halder, Bushra Dohai, Pascal Falter-Braun, Daniel Krappmann
10 [GO] Biochemical Society Transactions 2023―Dez―18 Aminoacyl-tRNA synthetase interactions in SARS-CoV-2 infection Debjit Khan, Paul L. Fox
11 [GO] Biochemical Journal 2023―Aug―16 Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases? Douglas B. Kell, Etheresia Pretorius
12 [GO] Bioscience Reports 2023―Jul―27 Surfactant Replacement Therapy as Promising Treatment for COVID-19: an Updated Narrative Review Khaled Kh�h, Alaa Ramadan, Ahmed Othman, Neveen Refaey, Amr Alrosasy, Ayoub Rezkallah, Toka Heseba, Mostafa Hossam El Din Moawad, Ammar Mektebi, Sewar A Elejla, Mohamed Abouzid, Basel Abdelazeem
13 [GO] Bioscience Reports 2023―Jul―24 The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy Abdulla Abu-Bakr Badawy
14 [GO] Biochemical Society Transactions 2023―Jun―09 Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence Xiyuan Bai, Tony Schountz, Ashley M. Buckle, Janet L. Talbert, Robert A. Sandhaus, Edward D. Chan
15 [GO] Biochemical Journal 2023―Mai―31 Key Allosteric and Active Site Residues of SARS-CoV-2 3CLpro Are Promising Drug Targets Kenana Al Adem, Juliana C. Ferreira, Samar Fadl, Morad Mustafa, Wael M. Rabeh
16 [GO] Bioscience Reports 2023―Mai―22 COVID-19 Associated Thyroid Dysfunction and Other Comorbidities and Its Management Using Phytochemical-Based Therapeutics- A Natural Way Arpana Parihar, Shivani Malviya, Raju Khan, Ajeet Kaushik, Ebrahim Mostafavi
17 [GO] Biochemical Society Transactions 2023―Mai―18 Mechanisms of impairment of interferon production by SARS-CoV-2 Huy-Dung Hoang, Parisa Naeli, Tommy Alain, Seyed Mehdi Jafarnejad
18 [GO] Bioscience Reports 2023―Mrz―06 Acid-Base Imbalance as a Risk Factor for Mortality among COVID-19 Hospitalized Patients Nosayba Al-Azzam, Basheer Khassawneh, Sayer Al-Azzam, Reema Karasneh, Mamoon A Aldeyab
19 [GO] Bioscience Reports 2023―Jan―18 Polypharmacology of ambroxol in the treatment of COVID-19 Ziyuan Wang, Minghui Yang, Xi Chen, Rongxin Xiao, Yu Dong, Ming Chu, Guojie Song, Yuedan Wang
20 [GO] Biochemical Society Transactions 2022―Nov―24 Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O'Hehir, Menno C. van Zelm
21 [GO] Clinical Science 2022―Nov―11 Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs Jaroslav Pelisek, Benedikt Reutersberg, Urs F Greber, Alexander Zimmermann
22 [GO] Clinical Science 2022―Okt―21 Therapeutic use of calpeptin in COVID-19 infection Jameel Inal, Ainura Paizuldaeva, Esmeralda Terziu
23 [GO] Biochemical Journal 2022―Okt―07 Therapeutic potential of metal ions for COVID-19: insights from the papain-like protease of SARS-CoV-2 Cameron Lee Shetler, Juliana C. Ferreira, Thyago H. S. Cardoso, Edson M.A. Silva, Nitin K. Saksena, Wael M. Rabeh
24 [GO] Biochemical Journal 2022―Sep―02 The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications Douglas B. Kell, Etheresia Pretorius
25 [GO] Clinical Science 2022―Jul―06 Casting a wide NET: an update on uncontrolled NETosis in response to COVID-19 infection Erin B. Taylor
26 [GO] Biochemical Journal 2022―Apr―05 Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity Gavin D Garland, Robert F Harvey, Thomas E Mulroney, Mie Monti, Stewart Fuller, Richard Haigh, Pehuén Pereyra Gerber, Michael R Barer, Nicholas J Matheson, Anne E Willis
27 [GO] Clinical Science 2022―Mrz―29 SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infection John D. Imig
28 [GO] Biochemical Journal 2022―Mrz―04 Programmed cell death: the pathways to severe COVID-19? Stefanie M. Bader, James P. Cooney, Marc Pellegrini, Marcel Doerflinger
29 [GO] Biochemical Journal 2022―Feb―23 A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications Douglas B. Kell, Gert Jacobus Laubscher, Etheresia Pretorius
30 [GO] Biochemical Society Transactions 2022―Jan―11 Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases Anoop Narayanan, Shay A. Toner, Joyce Jose
31 [GO] The Biochemist 2021―Dez―16 A pandemic in the age of next-generation sequencing Angela H. Beckett, Kate F. Cook, Samuel C. Robson
32 [GO] Clinical Science 2021―Dez―08 Erythrocytes increase endogenous sphingosine 1-phosphate (S1P) levels as an adaptive response to SARS-CoV-2 infection Martin Sebastian Winkler, Ralf A Claus, Mareike Schilder, Stefan Pöhlmann, Sina Coldewey, Julian Grundmann, Torben Fricke, Onnen Moerer, Konrad Meissner, Michael Bauer, Heike Hofmann-Winkler, Markus Gräler
33 [GO] Biochemical Society Transactions 2021―Dez―02 The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines Kensaku Murano, Youjia Guo, Haruhiko Siomi
34 [GO] Clinical Science 2021―Nov―22 The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147-receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease Elisa Avolio, Michele Carrabba, Rachel Milligan, Maia Kavanagh Williamson, Antonio Beltrami, Kapil Gupta, Karen T Elvers, Monica Gamez, Rebecca Foster, Kathleen Gillespie, Fergus Hamilton, David Arnold, Imre Berger, Andrew Davidson, Darryl J. Hill, Massimo Caputo, Paolo Madeddu
35 [GO] Biochemical Journal 2021―Sep―24 Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain Jessie L Gan, Ruiqi Huang, Abigail Kelley, Gabrielle Warner, Duncan McGregor, Vaughn V. Smider
36 [GO] Bioscience Reports 2021―Sep―14 Targeting Intra-Viral Conserved Nucleocapsid (N) Proteins as Novel Vaccines against SARS-CoVs Min Thura, Joel Xuan En Sng, Koon Hwee Ang, Jie Li, Abhishek Gupta, Jimmy Ming Hong, Cheng William Hong, Qi Zeng
37 [GO] The Biochemist 2021―Aug―23 Crowd sourcing yeast and rising above the pandemic: the SuperYeast project survival tale Naomi Wilkinson
38 [GO] Biochemical Journal 2021―Aug―13 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease Berta Canal, Allison W. McClure, Joseph F. Curran, Mary Wu, Rachel Ulferts, Florian Weissmann, Jingkun Zeng, Agustina P. Bertolin, Jennifer C. Milligan, Souradeep Basu, Lucy S. Drury, Tom D. Deegan, Ryo Fujisawa, Emma L. Roberts, Clovis Basier, Karim Labib, Rupert Beale, Michael Howell, John F.X. Diffley
39 [GO] Bioscience Reports 2021―Aug―05 Obesity, a major risk factor for immunity and severe outcomes of COVID-19 Mohammad Tohidul Amin, Kaniz Fatema, Sayama Arefin, Fahad Hussain, Dipty Rani Bhowmik, Mohammad Salim Hossain
40 [GO] Biochemical Society Transactions 2021―Aug―05 Host ADP-ribosylation and the SARS-CoV-2 macrodomain Nicolas C. Hoch
41 [GO] Clinical Science 2021―Aug―02 Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility Nayara Azinheira Nobrega Cruz, Danielle Stoll, Dulce Elena Casarini, Mariane Bertagnolli
42 [GO] Bioscience Reports 2021―Jul―30 SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 Lize M Grobbelaar, Chantelle Venter, Mare Vlok, Malebogo Ngoepe, Gert J Laubscher, Petrus J Lourens, Janami Steenkamp, Douglas Kell, Etheresia Pretorius
43 [GO] Essays in Biochemistry 2021―Jul―30 Roles of steroid receptors in the lung and COVID-19 Damien A. Leach, Greg N. Brooke, Charlotte L. Bevan
44 [GO] Bioscience Reports 2021―Jul―27 A lipidomic view of SARS-CoV-2 Kourosh Honarmand Ebrahimi, James McCullagh
45 [GO] Bioscience Reports 2021―Jul―22 Biochemical composition, transmission and diagnosis of SARS-CoV-2 Rajesh Ahirwar, Sonu Gandhi, Komal Komal, Geeta Dhaniya, Prem Prakash Tripathi, Vyas Madhavrao Shingatgeri, Krishan Kumar, Jai Gopal Sharma, Saroj Kumar
46 [GO] Biochemical Journal 2021―Jul―01 Author's overview: identifying SARS-CoV-2 antiviral compounds John F.X. Diffley
47 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease Chew Theng Lim, Kang Wei Tan, Mary Wu, Rachel Ulferts, Lee A. Armstrong, Eiko Ozono, Lucy S. Drury, Jennifer C. Milligan, Theresa U. Zeisner, Jingkun Zeng, Florian Weissmann, Berta Canal, Ganka Bineva-Todd, Michael Howell, Nicola O'Reilly, Rupert Beale, Yogesh Kulathu, Karim Labib, John F.X. Diffley
48 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase Souradeep Basu, Tiffany Mak, Rachel Ulferts, Mary Wu, Tom Deegan, Ryo Fujisawa, Kang Wei Tan, Chew Theng Lim, Clovis Basier, Berta Canal, Joseph F. Curran, Lucy S. Drury, Allison W. McClure, Emma L. Roberts, Florian Weissmann, Theresa U. Zeisner, Rupert Beale, Victoria H. Cowling, Michael Howell, Karim Labib, John F.X. Diffley
49 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase Jingkun Zeng, Florian Weissmann, Agustina P. Bertolin, Viktor Posse, Berta Canal, Rachel Ulferts, Mary Wu, Ruth Harvey, Saira Hussain, Jennifer C. Milligan, Chloe Roustan, Annabel Borg, Laura McCoy, Lucy S. Drury, Svend Kjaer, John McCauley, Michael Howell, Rupert Beale, John F.X. Diffley
50 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase Agustina P. Bertolin, Florian Weissmann, Jingkun Zeng, Viktor Posse, Jennifer C. Milligan, Berta Canal, Rachel Ulferts, Mary Wu, Lucy S. Drury, Michael Howell, Rupert Beale, John F.X. Diffley
51 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease Jennifer C. Milligan, Theresa U. Zeisner, George Papageorgiou, Dhira Joshi, Christelle Soudy, Rachel Ulferts, Mary Wu, Chew Theng Lim, Kang Wei Tan, Florian Weissmann, Berta Canal, Ryo Fujisawa, Tom Deegan, Hema Nagaraj, Ganka Bineva-Todd, Clovis Basier, Joseph F. Curran, Michael Howell, Rupert Beale, Karim Labib, Nicola O'Reilly, John F.X. Diffley
52 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease Berta Canal, Ryo Fujisawa, Allison W. McClure, Tom D. Deegan, Mary Wu, Rachel Ulferts, Florian Weissmann, Lucy S. Drury, Agustina P. Bertolin, Jingkun Zeng, Rupert Beale, Michael Howell, Karim Labib, John F.X. Diffley
53 [GO] Biochemical Journal 2021―Jul―01 An all-out assault on SARS-CoV-2 replication Ronald T. Hay
54 [GO] Bioscience Reports 2021―Jul―01 Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 Aline H de Nooijer, Inge Grondman, Simon Lambden, Emma J Kooistra, Nico AF Janssen, Matthijs Kox, Peter Pickkers, Leo AB Joosten, Frank van de Veerdonk, Marc Derive, Sebastien Gibot, Mihai G Netea
55 [GO] Bioscience Reports 2021―Jun―16 Heparanase as a Potential Player in SARS-CoV-2 Infection and Induced-Coagulopathy Safa Kinaneh, Iyad Khamaysi, Tony Karram, Shadi Hamoud
56 [GO] Essays in Biochemistry 2021―Mai―24 3D Bioprinting for fabrication of tissue models of COVID-19 infection Anisha Kabir, Pallab Datta, Julia Oh, Adam Williams, Veli Ozbolat, Derya Unutmaz, Ibrahim T. Ozbolat
57 [GO] Clinical Science 2021―Apr―21 Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat? Fedor Simko, Tomas Baka
58 [GO] The Biochemist 2021―Apr―09 The COVID-19 pandemic: impact on the molecular bioscience research community and beyond Pedro Ferreira, Dominika Gruszka, Derry Mercer
59 [GO] Biochemical Society Transactions 2021―Mrz―05 Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter? Devanshi Mishra, Chinmoy Sankar Dey
60 [GO] Bioscience Reports 2021―Feb―26 Lipidomic Alteration of Plasma in Cured COVID-19 Patients using UltraHigh-Performance Liquid Chromatography with High-Resolution Mass Spectrometry Yunpeng Bai, Wendong Huang, Yaocai Li, Changchun Lai, Sumei Huang, Guangwen Wang, Yuemei He, Linhui Hu, Chunbo Chen
61 [GO] Bioscience Reports 2021―Feb―24 Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates Mateus S.M. Serafim, Jadson C. Gertrudes, Débora M. A. Costa, Patricia R. Oliveira, Vinicius G. Maltarollo, Kathia Maria Honorio
62 [GO] Bioscience Reports 2021―Feb―24 The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage Junfang Wu, Mingming Zhao, Chenze Li, Yuxuan Zhang, Dao Wen Wang
63 [GO] Bioscience Reports 2021―Feb―23 Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
64 [GO] Clinical Science 2021―Feb―06 ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders Xi Cao, Li-Ni Song, Jin-Kui Yang
65 [GO] Clinical Science 2021―Jan―29 ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease Jithin Kuriakose, Augusto C. Montezano, Rhian M. Touyz
66 [GO] Clinical Science 2021―Jan―23 Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19 Maria A Pedrosa, Rita Valenzuela, Pablo Garrido, Carmen M Labandeira, Gemma Navarro, Rafael Franco, Jose Luis Labandeira-Garcia, Ana I Rodriguez-Perez
67 [GO] Bioscience Reports 2021―Jan―23 Hyperglycaemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: A meta-analysis Yan Yang, Zixin Cai, Jingjing Zhang
68 [GO] Bioscience Reports 2021―Jan―14 ACE/ACE2 balance might be instrumental to explain the certain comorbidities lead to severe COVID-19 cases Sarbashri Bank, Subrata Kumar De, Biswabandhu Bankura, Smarajit Maiti, Madhusudan Das, Gausal A Khan
69 [GO] Biochemical Journal 2021―Jan―14 The role of chemical biology in the fight against SARS-CoV-2 George M. Burslem
70 [GO] Clinical Science 2021―Jan―07 Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases Ravindra K. Sharma, Jing Li, Suraj Krishnan, Elaine M. Richards, Mohan K. Raizada, Rajesh Mohandas
71 [GO] Biochemical Society Transactions 2020―Dez―24 Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies Ilaria Manfredonia, Danny Incarnato
72 [GO] Bioscience Reports 2020―Dez―22 Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19 Guolian Zhao, Yazhou Xu, Jing Li, Xiaoli Cui, Xiaowen Tan, Hongyue Zhang, Liyun Dang
73 [GO] The Biochemist 2020―Dez―12 Uncloaking the invisible killer and developing an antidote to SARS-CoV-2 Andre Watson
74 [GO] Clinical Science 2020―Dez―11 ACE2, a multifunctional protein - from cardiovascular regulation to COVID-19 Michael Bader, Anthony J. Turner, Natalia Alenina
75 [GO] Bioscience Reports 2020―Dez―11 Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential Zubair A Nizamudeen, Emma-Ruoqi Xu, Vivin Karthik, Mohamed Halawa, Kenton P Arkill, Andrew Jackson, David O. Bates, Jonas Elmsley
76 [GO] Clinical Science 2020―Dez―09 ACE2: from protection of liver disease to propagation of COVID-19 Fiona J. Warner, Harinda Rajapaksha, Nicholas Shackel, Chandana B. Herath
77 [GO] The Biochemist 2020―Dez―09 Teaching and learning biochemistry in a pandemic (and beyond?) Chris Willmott
78 [GO] Emerging Topics in Life Sciences 2020―Dez―03 How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we know so far Sumana Sanyal
79 [GO] Clinical Science 2020―Dez―03 Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists U. Muscha Steckelings, Colin Sumners
80 [GO] Emerging Topics in Life Sciences 2020―Dez―01 The zoonotic potential of bat-borne coronaviruses Ny Anjara Fifi Ravelomanantsoa, Sarah Guth, Angelo Andrianiaina, Santino Andry, Anecia Gentles, Hafaliana Christian Ranaivoson, Cara E. Brook
81 [GO] Biochemical Society Transactions 2020―Dez―01 A pocket guide on how to structure SARS-CoV-2 drugs and therapies Dene R. Littler, Bruce J. MacLachlan, Gabrielle M. Watson, Julian P. Vivian, Benjamin S. Gully
82 [GO] Bioscience Reports 2020―Nov―30 Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical Xi Zhou, Dong Chen, Lan Wang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Bo Yang
83 [GO] Clinical Science 2020―Nov―25 ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19 Koichi Yamamoto, Hikari Takeshita, Hiromi Rakugi
84 [GO] Emerging Topics in Life Sciences 2020―Nov―17 Endothelial pulsatile shear stress is a backstop for COVID-19 Marvin A. Sackner, Jose A. Adams
85 [GO] Bioscience Reports 2020―Nov―17 Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. Gianluca E.M. Boari, Giulia Chiarini, Silvia Bonetti, Paolo Malerba, Gianluca Bianco, Cristina Faustini, Federico Braglia-Orlandini, Daniele Turini, Vittoria Guarinoni, Michele Saottini, Sara Viola, Giulia Ferrari-Toninelli, Giancarlo Pasini, Cristina Mascadri, Bianca Bonzi, Paolo Desenzani, Claudia Tusi, Eros Zanotti, Matteo Nardin, Damiano Rizzoni
86 [GO] Biochemical Society Transactions 2020―Nov―10 Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications Jiayue-Clara Jiang, Yan Zhang
87 [GO] Bioscience Reports 2020―Nov―04 Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 Chun Liang, Wenhao Niu, Feng Wu, Wenyue Cao, Zonggui Wu, Yu Chieh Chao, Fei Peng
88 [GO] Clinical Science 2020―Nov―04 ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV Lizelle Lubbe, Gyles E. Cozier, Delia Oosthuizen, K. Ravi Acharya, Edward D. Sturrock
89 [GO] Clinical Science 2020―Nov―02 ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery Enrique Lores, Jan Wysocki, Daniel Batlle
90 [GO] Biochemical Society Transactions 2020―Okt―21 Transmission and prevention of SARS-CoV-2 Zhongyi Wang, Yingying Fu, Zhendong Guo, Jiaming Li, Jingjing Li, Hongliang Cheng, Bing Lu, Qiang Sun
91 [GO] Bioscience Reports 2020―Okt―16 Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide? Abdulla A-B Badawy
92 [GO] Clinical Science 2020―Okt―16 Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease Carlos M. Ferrario, Sarfaraz Ahmad, Leanne Groban
93 [GO] The Biochemist 2020―Okt―12 Understanding the impact of COVID-19 on early career molecular bioscientists Dominika Gruszka
94 [GO] Clinical Science 2020―Sep―29 Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19 Nigel M. Hooper, Daniel W. Lambert, Anthony J. Turner
95 [GO] Clinical Science 2020―Sep―09 Correction: Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission
96 [GO] Clinical Science 2020―Sep―01 Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera Mohamad Aman Jairajpuri, Shoyab Ansari
97 [GO] Clinical Science 2020―Aug―21 Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission Daniella S. Battagello, Guilherme Dragunas, Marianne O. Klein, Ana L.P. Ayub, Fernando J. Velloso, Ricardo G. Correa
98 [GO] Clinical Science 2020―Aug―04 Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies Thiago Gomes Heck, Mirna Stela Ludwig, Matias Nunes Frizzo, Alberto Antonio Rasia-Filho, Paulo Ivo Homem de Bittencourt
99 [GO] Bioscience Reports 2020―Jul―29 Blood routine test in mild and common 2019 coronavirus (COVID-19) patients Dodji Kossi Djakpo, Zhiquan Wang, Rong Zhang, Xin Chen, Peng Chen, Malyn Martha Lilac ketisha Antoine
100 [GO] Clinical Science 2020―Jun―16 Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy Jameel M. Inal
101 [GO] Clinical Science 2020―Jun―16 SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure Alain R. Thierry, Benoit Roch
102 [GO] Biochemical Society Transactions 2020―Jun―08 α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19 Spencer J. Williams, Ethan D. Goddard-Borger
103 [GO] Clinical Science 2020―Jun―08 Covid-19: the renin-angiotensin system imbalance hypothesis Katharina Lanza, Lucas G. Perez, Larissa B. Costa, Thiago M. Cordeiro, Vitria A. Palmeira, Victor T. Ribeiro, Ana Cristina Simões e Silva
104 [GO] Bioscience Reports 2020―Mai―22 Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19 Anas Shamsi, Taj Mohammad, Saleha Anwar, Mohamed Alajmi, Afzal Hussain, Md. Tabish Rehman, Asimul Islam, Md. Imtaiyaz Hassan
105 [GO] Clinical Science 2020―Mai―22 Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs Sayeed ur Rehman, Mohammad Tabish
106 [GO] Bioscience Reports 2020―Mai―07 A virus that has gone viral: Amino-acid mutation in S protein of Indian-isolate of Coronavirus COVID-19 might impact receptor-binding, thus infectivity Priyanka Saha, Arup Kumar Banerjee, Prem Prakash Tripathi, Amit Kumar Srivastava, Upasana Ray
107 [GO] Biochemical Journal 2020―Apr―29 Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle Samantha Gildenhuys
108 [GO] Clinical Science 2020―Apr―07 ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19 Rhian M. Touyz, Hongliang Li, Christian Delles
109 [GO] Clinical Science 2020―Mrz―13 Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Daniel Batlle, Jan Wysocki, Karla Satchell
110 [GO] Biochemical Journal 2020―Feb―21 Processing of the SARS-CoV pp1a/ab nsp7-10 region Boris Krichel, Sven Falke, Rolf Hilgenfeld, Lars Redecke, Charlotte Uetrecht
 [1] 

110 Ergebisse       Seite 1




[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec